Solid Biosciences Inc. share price logo

Solid Biosciences Inc.

NASDAQ: SLDB

Small Cap

$7.51

+0.20

(+2.74%)

Live

as on

Solid Biosciences Inc. Stock Performance

as on June 19, 2026 at 1:16 am IST

  • Day's Low

    Day's High

    $7.49
    $7.87
    downward going graph

    0.27%

    Downside

    4.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.79
    $8.87
    downward going graph

    49.53%

    Downside

    18.06%

    Upside

    downward going graph

Solid Biosciences Inc. share price movements today

Previous Close
$7.31
Open
$7.58
Volume
1.3M
Day's Low - High
$7.49 - $7.87
52 Week Low - High
$3.79 - $8.87

Solid Biosciences Inc. Historical Returns

1 Month Return
+ 12.29 %
3 Month Return
+ 2.67 %
1 Year Return
+ 57.2 %
3 Year Return
+ 4.28 %
5 Year Return
-87.54 %

Solid Biosciences Inc. Stock Fundamentals & Key Indicators

Check Solid Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$724.6M

EPS (TTM)

-1.9569

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-194.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-57.37%

Solid Biosciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Solid Biosciences Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Solid Biosciences Inc. image
Solid Biosciences Inc.
BUY$724.6M-87.54%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.6B59.83%71.0112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$115.0B144.34%26.8835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$64.4B13.01%15.0229.65%0.58%

Stock Returns calculator for Solid Biosciences Inc. Stock including INR - Dollar returns

The Solid Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Solid Biosciences Inc. investment value today

Current value as on today

₹1,76,254

Returns

₹76,254

(+76.25%)

Returns from Solid Biosciences Inc. Stock

₹61,505 (+61.51%)

Dollar Impact

₹14,749 (+14.75%)

Analyst Recommendation on Solid Biosciences Inc. Stock

Based on 15 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 15 analysts, 80% of analysts recommend a 'BUY' rating for Solid Biosciences Inc.. Average target price of $17.38

Solid Biosciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Solid Biosciences Inc..

What analysts predicted

56.79%UPSIDE

Target Price

$17.38

Current Price

$7.51

Analyzed by

15 Analysts

Target

$17.38

Solid Biosciences Inc. target price $17.38, a slight upside of 56.79% compared to current price of $7.51. According to 15 analysts rating.

Indian Investors' Interest in Solid Biosciences Inc. Stock

Search interest for Solid Biosciences Inc. Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Solid Biosciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
4
-
-
-
3
-
-
-
-
-
Gross Profit
0
0
-1
0
0
0
0
0
0
0
Operating Income
-22
-26
-27
-35
-39
-40
-41
-48
-49
-57
EBITDA
-20
-23
-23
-32
-42
-38
-39
-45
-49
-56
Interest Expense
1
0
0
0
0
0
0
0
-
-
Depreciation
0
0
1
0
0
0
0
0
0
0
Income Before Tax
-20
-24
-25
-32
-42
-39
-39
-45
-49
-56
Income Tax Expense
4
0
-1
-
0
-
-
-
-
-
Net Income
-20
-24
-25
-32
-42
-39
-39
-45
-49
-56
Net Profit Margin
-429.39%
0.00%
0.00%
0.00%
-1363.54%
0.00%
0.00%
0.00%
0.00%
0.00%

Solid Biosciences Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
3
13
8
-
-
-
Gross Profit
0
0
-1
-2
-3
13
8
-2
-2
-1
Operating Income
-25
-54
-75
-119
-86
-72
-106
-104
-129
-179
EBITDA
-25
-54
-74
-116
-84
-69
-96
-93
-121
-172
Interest Expense
-
-
-
-
-
0
20
0
0
-
Depreciation
-
0
1
2
3
2
2
2
2
1
Income Before Tax
-23
-53
-74
-117
-88
-72
-85
-96
-124
-174
Income Tax Expense
-2
-1
0
-1
1
0
-20
-
-
-
Net Income
-21
-52
-74
-117
-88
-72
-85
-96
-124
-174
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-2647.38%
-530.01%
-1062.28%
0.00%
0.00%
0.00%

Solid Biosciences Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-24
-25
-32
-42
-39
-39
-45
-49
-56
Operating Cash Flow
-25
-21
-23
-29
-31
-37
-33
-53
-47
Investing Cash Flow
-38
-5
-10
38
-27
-32
-45
47
44
Financing Cash Flow
107
5
3
6
189
-1
1
5
239
Change in Cash
43
-21
-31
15
130
-71
-77
-1
236

Solid Biosciences Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-53
-74
-117
-88
-72
-85
-96
-124
-174
Operating Cash Flow
-43
-70
-92
-56
-77
-97
-94
-100
-156
Investing Cash Flow
10
-26
24
6
-91
59
9
-16
-58
Financing Cash Flow
77
131
57
128
134
74
3
122
194
Change in Cash
44
34
-10
78
-33
36
-81
6
-20

Global Institutional Holdings in Solid Biosciences Inc.

Funds
Holdings
Geode Capital Management, LLC
1.32%
Citadel Advisors Llc
2.64%
Point72 Asset Management, L.P.
2.08%
Nantahala Capital Management, LLC
1.63%
State Street Corp
1.11%
See all

Insights on Solid Biosciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SLDB has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SLDB stock has moved up by 12.3%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SLDB has outperformed top 5 stocks with highest market-cap in its industry

About Solid Biosciences Inc.

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopathy, which is in preclinical phase; SGT-401 for the treatment of BAG3-mediated dilated cardiomyopathy that is in preclinical phase; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, which is in discovery phase; and other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries; genetic regulators, such as promoters, UTRs, and introns; immunomodulation technologies; manufacturing purity; and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc.; and a license agreement with the University of Washington, University of Missouri, University of Florida, and ICS Maugeri S.p.A. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.
OrganisationSolid Biosciences Inc.
Headquarters500 Rutherford Avenue, Charlestown, MA, United States, 02129
IndustryBiotechnology
CEOMr. Alexander G. Cumbo
E-voting on sharesClick here to vote

Key Management of Solid Biosciences Inc.

Name

Title

Mr. David Tyronne Howton Jr., J.D.

COO & Secretary

Dr. Gabriel Brooks M.D.

Chief Medical Officer

Ms. Nicole Anderson

Senior Director of Investor Relations & Corporate Communications

Dr. Jessie Hanrahan Ph.D.

Chief Regulatory & Preclinical Operations Officer

Mr. Kevin Tan C.F.A.

CFO & Treasurer

Mr. Paul Herzich

Chief Technology Officer

Mr. Ian F. Smith A.C.A., C.P.A.

Executive Chair

Mr. Alexander G. Cumbo

President, CEO & Director

Mr. Ilan Ganot

Co-founder, Strategic Advisor to the CEO & Director

Ms. Annie Ganot

Co-Founder & VP of Patient Advocacy

FAQs

What is Solid Biosciences Inc. share price today?

Solid Biosciences Inc. share price today is $7.51 as on . Solid Biosciences Inc. share today touched a day high of $7.87 and a low of $7.49.

What is the 52 week high and 52 week low for Solid Biosciences Inc. share?

Solid Biosciences Inc. share touched a 52 week high of $8.87 on and a 52 week low of $3.79 on . Solid Biosciences Inc. stock price today i.e. is trending at $7.51,which is 15.30% down from its 52 week high and 98.15% up from its 52 week low.

What is Solid Biosciences Inc.'s market capitalisation today?

Solid Biosciences Inc. market capitalisation is $0.00T as on .

How to invest in Solid Biosciences Inc. Stock (SLDB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Solid Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Solid Biosciences Inc. Shares that will get you 0.1997 shares as per Solid Biosciences Inc. share price of $7.51 per share as on June 18, 2026 at 7:46 pm IST.

What is the minimum amount required to buy Solid Biosciences Inc. Stock (SLDB) from India?

Indian investors can start investing in Solid Biosciences Inc. (SLDB) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Solid Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Solid Biosciences Inc. share’s latest price of $7.51 as on June 18, 2026 at 7:46 pm IST, you will get 1.3316 shares of Solid Biosciences Inc.. Learn more about fractional shares .

What are the returns that Solid Biosciences Inc. has given to Indian investors in the last 5 years?

Solid Biosciences Inc. stock has given -87.54% share price returns and 27.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?